This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Posts with tag EMA
Sort by Latest
- Sort by Latest
- Sort by Views
EMA’s envisaged risk-based and human-centric approach to regulate AI
Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the life sciences sector. This article is part of our new series, which will highlight different legal angles to consider when implementing AI in the life sciences and healthcare industry.
Artificial Intelligence (“AI”) has emerged as a transformative force in the healthcare industry, and its significance for the pharmaceutical sector is particularly profound....
September 14, 2023
6 min read
Proposed reform of the EU pharmaceutical legislation:...
This article is part of a series that covers the proposed...
June 27, 2023
4 min read
Single-arm clinical trials: EMA launches consultat...
In contrast to randomised controlled trials (RCTs), single-arm...
April 26, 2023
2 min read